Including Therapeutic Food, Dietary Vitamin and Mineral Supplementation - 2nd edition
В отчете представлено описание комплексной модели лечения детского туберкулеза и опыта работы проекта в Таджикистане. На основе этого опыта сделаны не...оторые выводы и рекомендации по расширению масштабов оказания противотуберкулезной помощи детям в регионе Центральной Азии и Восточной Европы.
more
Презентация об опыте и результатах клинического исследования endTB
Лечить пациента, а не болезнь: ориентированный на человека подход
7й симпозиум по вопросам лечения туберкулеза - презентация
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002514 March 1, 2018
Médicaments et dispositifs médicaux pour une population de
10 000 personnes pendant environ 3 mois
(Régions sanitaires de Tonkpi, Cavally-Guemon et Gbokle-Nawa-San Pedro) Rapport de Mission Exploratoire
Guide pratique à l’usage des sages-femmes, médecins spécialisés en obstétrique et personnel de santé devant faire face à des urgences obstétricales. Ce guide a été conçu comme un outil qui permette de protéger la mère et son enfant dans un environnement défavorable. Il est destiné a...ux sages-femmes, médecins spécialisés en obstétrique et personnel de santé devant faire face à des urgences obstétricales.
more
Презентация о туберкулезе и диабете
В борьбе с туберкулезом достигнуты значительные прорывы, среди которых ускоренные и более точные методы диагностики и первые новые лекарственные средства за 50 л...т, однако сохраняется губительное отставание во внедрении этих нововведений в практику и обеспечения доступа к ним для уязвимых и социально ущемленных групп населения, в том числе заключенных, людей, живущих с ВИЧ, внутренних и внешних мигранты и наркопотребителей
more
The growing challenges for people in low and middle-income countries to access new medicines.
Analysis 58
2nd edition - Published in 2003, the first WHO/HAI medicine prices manual Medicine Prices – A
New Approach to Measurement Draft for field-testing provides a draft methodology and tools to conduct national medicine prices and availability surveys. This second edition of the survey manual has been... updated to reflect the wealth of practical
experience in conducting medicine prices and availability surveys garnered in the project’s first two phases.
more
Презентация на тему диагностики туберкулеза
This article examines the activities of national and international actors in Pharmaceutical Services (PS) in Mozambique from 2007 to 2012, focusing on the public provision of HIV/Aids, malaria and tuberculosis medicines. It describes how PS functions in the country, what actors are involved in this ...area and the relations among them, pursuing salient issues in the modus operandi of partners in cooperation.
more
PLOS Medicine | DOI:10.1371/journal.pmed.1002088 August 23, 2016
Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this paper, we summarize the experience and results of providing ART and implementing contingency plans during acute instability in the Central African Republic (CAR) and Yemen.
Two adjectives raise an issue for communicators working on Chagas disease (CD): “invisible and silent”. Two adjectives that can be ascribed to other neglected tropical diseases (NTD), but which are part of the essence of CD. Bringing CD out of its situation of neglect and oblivion is a mission e...ntrusted mainly to the world of communication as well as of science, politics and financial resources. However, communication has not always been considered among the priorities in the approach to the disease, except in valuable exceptions, some of which we have seen in the preceding article.
more
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...tems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
more